Tag: Biotech funding
Biotech IPOs surge sixfold to $3.72 Billion in Q1 2024, highest...
Renewed investor optimism drives an increase in biotech IPO activity, with a record-setting first quarter following a two-year downturn
Biopharma’s optimism rises 13%, yet falls short of 2022 peak, reports...
Industry shows growing confidence in 12-month growth, but geopolitical tensions and drug pricing pressures temper expectations